## Core Concept
Cutaneous vasoconstriction refers to the narrowing of blood vessels in the skin, which is a critical physiological response to cold exposure or stress. This response is primarily mediated by the sympathetic nervous system. The key players in this process include specific adrenergic receptors.

## Why the Correct Answer is Right
The correct answer, **α1-adrenergic receptors**, are key mediators of cutaneous vasoconstriction. When stimulated by catecholamines (like norepinephrine), these receptors cause smooth muscle contraction in blood vessel walls, leading to vasoconstriction. This mechanism helps to reduce heat loss from the body surface by decreasing blood flow to the skin.

## Why Each Wrong Option is Incorrect
* **Option A:** β2-adrenergic receptors are primarily involved in vasodilation, particularly in skeletal muscle and liver. Their stimulation leads to the relaxation of smooth muscle in blood vessels, which is the opposite of vasoconstriction.
* **Option B:** M2 muscarinic receptors are mainly found in the heart, where they mediate a decrease in heart rate and contractility. They are not primarily involved in cutaneous vasoconstriction.
* **Option D:** D1-like dopamine receptors are involved in vasodilation in certain vascular beds, particularly in the renal and mesenteric arteries. They do not play a primary role in cutaneous vasoconstriction.

## Clinical Pearl / High-Yield Fact
A key clinical point to remember is that individuals with Raynaud's phenomenon exhibit exaggerated cutaneous vasoconstriction in response to cold or stress, leading to episodic ischemia of the fingers and toes. This condition highlights the importance of α1-adrenergic receptors and other factors in regulating cutaneous blood flow.

## Correct Answer: C. α1-adrenergic receptors